featured
Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory B-ALL: 3-Year Update
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial
J. Clin. Oncol 2022 Nov 18;[EPub Ahead of Print], TW Laetsch, SL Maude, S Rives, H Hiramatsu, H Bittencourt, P Bader, A Baruchel, M Boyer, B De Moerloose, M Qayed, J Buechner, MA Pulsipher, GD Myers, HE Stefanski, PL Martin, E Nemecek, C Peters, G Yanik, SL Khaw, KL Davis, J Krueger, A Balduzzi, N Boissel, R Tiwari, D O'Donovan, SA GruppFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.